Senate Finance Committee Chairman Chuck Grassley insists that the long-delayed drug-price bill he is co-sponsoring will get a vote this year. Grassley worries that if the bill doesn't pass, drugmakers will charge whatever they want for Covid-19 related drugs. But drug lobbyists are counting on the coronavirus making drug pricing reform obsolete. Emma Court and Riley Griffin spoke to Senator Grassley about the bill.
Podden och tillhörande omslagsbild på den här sidan tillhör Bloomberg. Innehållet i podden är skapat av Bloomberg och inte av, eller tillsammans med, Poddtoppen.
